Trump MMR Lethal Claim Corrected by Oz
Analysis based on 19 articles · First reported Aug 23, 2026 · Last updated Aug 23, 2026
The executive order and subsequent controversy could affect vaccine manufacturers like Merck, potentially delaying or complicating product development and regulatory approvals. Public health agencies and healthcare providers may face increased operational challenges and public confusion, impacting immunization rates and potentially exacerbating measles outbreaks.
President Donald Trump signed an executive order directing the United States — United States Department of Health and Human Services to split the combined measles, mumps, and rubella (MMR) vaccine into three separate shots, claiming without evidence that the combined vaccine 'could be quite lethal.' The order also moved several other vaccines into a high-risk category and instructed states to review school-entry immunization laws. Dr. Mehmet Oz, administrator of the United States — Centers for Medicare & Medicaid Services, publicly clarified on CBS's Face the Nation that the MMR vaccine is 'not a lethal vaccine,' contradicting the president's suggestion. Merck, the manufacturer of the MMR vaccine, stated it could not offer separate shots for at least another 10 years. Public health officials and fact-checkers, including the CDC, FactCheck.org, and PolitiFact, debunked Trump's claim. The order has drawn criticism from Senator Bill Cassidy and public health experts like Joshua Sharfstein, who warned it could increase vaccine hesitancy during the largest measles outbreak in decades, with 2,777 confirmed cases as of August 20.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard